Market Overview:

Blood Transfusion Diagnostics market is expected to reach USD 2.45 billion at a CAGR of 8.2% during the forecast period.

Exclusive Overview by MarketResearchFuture.com of Global Blood Transfusion Diagnostics Market Research Report 2019 to 2023, with respect to region specific market growth and competitive analysis on the basis of major players present in the market. Detail analysis on possible segments and sub segments of the market. Provide country level analysis of the market with respect to the current market size and future prospective.

The technological advancements and deployment of automation in blood banks are anticipated to have a favorable impact on the proliferation of the blood transfusion diagnostics market in during the assessment period. The market resonates strong opportunities for growth and the initiatives undertaken by the government for promoting blood donation is further prognosticated to catalyze the expansion of the market.

Competitive Landscape:

Major players in this market are: Ortho Clinical Diagnostics (U.S), Immucor (U.S), Beckman Coulter (U.S),  Grifols (Spain), Thermo Fisher Scientific, Inc. (U.S.), Roche Diagnostics (Switzerland), bioMérieux (France), Bio-Rad Laboratories, Inc. (U.S.), Siemens Healthineers (Germany), Ortho Clinical Diagnostics, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Novartis AG (Switzerland), Beckman Coulter, Inc. (U.S.), Diagast (France), Abbott Diagnostics (U.S), BAG healthcare (Germany),  DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Quidel (U.S), Hologic/Gen-Probe (U.S), Biokit (Spain).

Regional Analysis:

The regional segmentation of the global blood transfusion pumps market can segment the market into regional markets namely the Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). Due to the availability of advanced medical facilities, awareness programs conducted by the government bodies & non-government organizations government funding for research & development (R&D), increase in the use of nucleic acid amplification test, and the presence of key market players, North America is a bigger regional market than South America. In North America, the USA and Canada are the pivotal  country-specific markets. Argentina and Brazil are two strong economies that have the potential to grow as suitable markets in South America.

Market Segmentation:

The global blood transfusion diagnostics market has been segmented on the basis of blood product, end user, technology, and lastly, region. Based on blood product, this market has been segmented into albumin, immunoglobulin preparations, plasma, platelets, and red blood cells. The segmentation based basis of end users segments the market into blood banks, clinics, hospitals, and laboratories. 

The technology-based segmentation segments the market into enzyme-linked immunosorbent assay (ELISA), fluorescence assay, nucleic acid amplification, and western blot. ELISA has been sub-segmented into chemiluminescence immunoassay, colorimetric immunoassay, and fluorescence immunoassay. Nucleic acid amplification has been sub-segmented into Thermomechanical Analysis (TMA) and Real-Time Polymerase chain reaction (PCR).

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com